7:33 AM · 17 April 2020

Economic calendar: Earnings dominate Friday's calendar

  • Markets rally on coronavirus drug report

  • Final European CPI reading for March

  • Procter & Gamble to report earnings ahead of opening bell

Moods on the global markets are improving with more and more countries outlining steps to reopen economies. Reports saying that a coronavirus drug developed by Gilead Science (GILD.US) is also doing its part. Simultaneously, markets are ignoring disastrous GDP data from China. DAX is expected to open around 300 pts above yesterday's close. There are no data releases scheduled for today that could turn to be major market movers so traders should focus on newsflow and earnings. Schlumberger, the US oil services company, will release a report ahead of the US session open and it may offer important insight into the situation in the oil sector.

10:00 am BST - Euro area, CPI inflation for March (final). Preliminary release: 0.7%

3:00 pm BST - US, leading index for March. Expected: -7%. Previous: 0.1%

6:00 pm BST - Baker Hughes US oil rig count. Last week: 504 

Central bankers' speeches

  • 2:00 pm BST - Fed's Bullard

  • 2:00 pm BST - ECB's Rehn

Noteworthy earnings releases

  • Procter & Gamble (PG.US) - before market opens

  • Schlumberger (SLB.US) - before market opens

  • State Street Corporation (STT.US) - before market opens

  • Citizens Financial Groups (CFG.US) - before market opens

17 October 2025, 7:03 PM

Daily summary: Trump remarks helps Wall Street 📈Precious metals decline

17 October 2025, 5:37 PM

Fed's Musalem remarks on the US economy and tariffs🗽

17 October 2025, 12:37 PM

The AI Fever: Bubble or Will It Keep Rising?

17 October 2025, 10:01 AM

BREAKING: Final inflation reading matches expectations. Core HICP inflation marginally higher

Join over 1 700 000 XTB Group Clients from around the world

The financial instruments we offer, especially CFDs, can be highly risky. Fractional Shares (FS) is an acquired from XTB fiduciary right to fractional parts of stocks and ETFs. FS are not a separate financial instrument. The limited corporate rights are associated with FS.
This page was not created for investors residing in Brazil. This brokerage is not authorized by the Comissão de Valores Mobiliários (CVM) or the Brazilian Central Bank (BCB). The content of this page should not be characterized as an investment offer in Brazil or for investors residing in that country.
Losses can exceed deposits